McCleery A, Nuechterlein KH (2019) Cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerations. Dialogues Clin Neurosci 21:239–248
Gualtieri CT, Morgan DW (2008) The frequency of cognitive impairment in patients with anxiety, depression, and bipolar disorder: an unaccounted source of variance in clinical trials. J Clin Psychiatry 69:1122–1130
Harvey PD (2019) Domains of cognition and their assessment. Dialogues Clin Neurosci 21:227–237
Wang J, Wu X, Lai W et al (2017) Prevalence of depression and depressive symptoms among outpatients: a systematic review and meta-analysis. BMJ Open 7:e017173
Malhi GS, Mann JJ (2018) Depression. Lancet 392:2299–2312
Loprinzi PD (2019) Interrelationships between depression, exercise and subjective memory complaints. Rev Neurol (Paris) 175:319–323
Bortolato B, Carvalho AF, McIntyre RS (2014) Cognitive dysfunction in major depressive disorder: a state-of-the-art clinical review. CNS Neurol Disord Drug Targets 13:1804–1818
Varghese S, Frey BN, Schneider MA, Kapczinski F, de Azevedo CT (2022) Functional and cognitive impairment in the first episode of depression: a systematic review. Acta Psychiatr Scand 145:156–185
Zhang BH, Feng L, Feng Y et al (2020) The effect of cognitive impairment on the prognosis of major depressive disorder. J Nerv Ment Dis 208:683–688
Lee RS, Hermens DF, Porter MA, Redoblado-Hodge MA (2012) A meta-analysis of cognitive deficits in first-episode Major Depressive Disorder. J Affect Disord 140:113–124
Trivedi MH, Rush AJ, Wisniewski SR et al (2006) Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 163:28–40
Vicent-Gil M, Keymer-Gausset A, Serra-Blasco M et al (2018) Cognitive predictors of illness course at 12 months after first-episode of depression. Eur Neuropsychopharmacol 28:529–537
Czerwińska A, Pawłowski T (2020) Cognitive dysfunctions in depression—significance, description and treatment prospects. Psychiatr Pol 54:453–466
Liu L, Lv X, Zhou S et al (2021) The effect of selective serotonin reuptake inhibitors on cognitive impairment in patients with depression: A prospective, multicenter, observational study. J Psychiatr Res 141:26–33
Carvalho AF, Sharma MS, Brunoni AR, Vieta E, Fava GA (2016) The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: a critical review of the literature. Psychother Psychosom 85:270–288
Lv X, Si T, Wang G et al (2016) The establishment of the objective diagnostic markers and personalized medical intervention in patients with major depressive disorder: rationale and protocol. BMC Psychiatry 16:240
Hayasaka Y, Purgato M, Magni LR et al (2015) Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials. J Affect Disord 180:179–184
Furukawa TA, Cipriani A, Cowen PJ, Leucht S, Egger M, Salanti G (2020) Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis. Focus (Am Psychiatr Publ) 18:211–219
Shi C, Kang L, Yao S et al (2015) The MATRICS consensus cognitive battery (MCCB): co-norming and standardization in China. Schizophr Res 169:109–115
Shin JH (2009) Application of repeated-measures analysis of variance and hierarchical linear model in nursing research. Nurs Res 58:211–217
Gueorguieva R, Krystal JH (2004) Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiatry 61:310–317
Zu S, Wang D, Fang J et al (2021) Comparison of residual depressive symptoms, functioning, and quality of life between patients with recurrent depression and first episode depression after acute treatment in China. Neuropsychiatr Dis Treat 17:3039–3051
Luo LL, Chen X, Chai Y, Li JH, Zhang M, Zhang JN (2013) A distinct pattern of memory and attention deficiency in patients with depression. Chin Med J (Engl) 126:1144–1149
Suciu BD, Păunescu RL, Micluţia IV (2021) Assessment of cognitive performances in major depressed patients: a 6-month follow-up study. Int J Psychiatry Clin Pract 25:378–384
Paelecke-Habermann Y, Pohl J, Leplow B (2005) Attention and executive functions in remitted major depression patients. J Affect Disord 89:125–135
Wang G, Si TM, Li L et al (2019) Cognitive symptoms in major depressive disorder: associations with clinical and functional outcomes in a 6-month, non-interventional, prospective study in China. Neuropsychiatr Dis Treat 15:1723–1736
Lim B, Sproule BA, Zahra Z, Sunderji N, Kennedy SH, Rizvi SJ (2020) Understanding the effects of chronic benzodiazepine use in depression: a focus on neuropharmacology. Int Clin Psychopharmacol 35:243–253
Duan Y, Wei J, Geng W et al (2019) The effect of short-term use of benzodiazepines on cognitive function of major depressive disorder patients being treated with antidepressants. J Affect Disord 256:1–7
留言 (0)